| 摘要 |
<p>The present invention relates to the use of one or more first compound(s) having a beta3-adrenoceptor agonistic effect and one or more second compound(s) having a beta1/beta2-adrenoceptor antagonistic effect for the preparation of a medicament for treating and/or preventing cardiovascular diseases and diseases related thereto, such as arterial diseases, ischemic and failing cardiac diseases, including heart failure, conditions related to metabolic syndrome, or angiogenesis-related diseases, wherein said one or more first compound(s) and said one or more second compound(s) are used as combined preparation for simultaneous, separate or sequential use. The invention further provides methods and composition for treating the above diseases.</p> |
